Before the bell, take a look at the businesses that are in the news.
Chemours: The chemical business saw a 3% increase in shares after UBS upgraded it from a buy recommendation to a neutral one. The analyst predicted that the stock will perform better in the coming year due to favourable demand and price drivers for refrigerants.
Tempus AI — After receiving buy or overweight ratings from multiple Wall Street institutions, the health care diagnostics business saw a nearly 4% increase in share price. In June, Tempus AI made its Nasdaq debut. Tempus AI employs artificial intelligence to evaluate medical findings.
Intel – The chip manufacturer continued its comeback this week, rising 2.7% in early morning trading. As of now, shares have increased by about 6.1%.
Troy’s Helen Due to a significant loss on earnings, shares of the parent company of Oxo and Hydro Flask dropped by more than 25%. Excluding items, the corporation made 99 cents per share. FactSet surveyed analysts, and they predicted a $1.59 per share profit. The outlook for quarterly sales was also lower than expected.
Nvidia: Following KeyBanc’s increase in price target to $180, which implies a gain of more than 40% from Monday’s finish, the chipmaker’s shares increased by more than 1%. “We are not seeing any signs of a demand pause as the demand for H100 remains robust,” KeyBanc stated, despite the upcoming launch of Blackwell in 2H24.
BP: The massive oil and gas corporation warned it expects to record an impairment of up to $2 billion, which caused its shares listed on the American stock exchange to drop more than 4%. Additionally, BP observes low margins from its refining division.
Source (CNBC)
